Taghizade, N. Et Al. 2023. Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.. The Journal of allergy and clinical immunology , vol.152, no.6 , 1634-1645.

Taghizade, N., Babayeva, R., Kara, A., Karakus, I. S., Catak, M. C., Bulutoglu, A., ... Haskologlu, Z. S.(2023). Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.. The Journal of allergy and clinical immunology , vol.152, no.6, 1634-1645.

Taghizade, Nigar Et Al. "Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.," The Journal of allergy and clinical immunology , vol.152, no.6, 1634-1645, 2023

Taghizade, Nigar Et Al. "Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.." The Journal of allergy and clinical immunology , vol.152, no.6, pp.1634-1645, 2023

Taghizade, N. Et Al. (2023) . "Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.." The Journal of allergy and clinical immunology , vol.152, no.6, pp.1634-1645.

@article{article, author={Nigar Taghizade Et Al. }, title={Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.}, journal={The Journal of allergy and clinical immunology}, year=2023, pages={1634-1645} }